Efficacy of NY-198 against experimental Legionnaires disease (Q39832353)

15 September 2017

Efficacy of NY-198 against experimental Legionnaires disease (English)

1 reference

15 September 2017

Kohno S

1 reference

15 September 2017

Yamaguchi K

1 reference

15 September 2017

Dohtsu Y

1 reference

15 September 2017

Koga H

1 reference

15 September 2017

Hayashi T

1 reference

15 September 2017

Hirota M

1 reference

15 September 2017

Saito A

1 reference

15 September 2017

Hara K

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 September 1988

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

1427-1429

1 reference

Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175881

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175881

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175881

In vitro and in vivo activity of NY-198, a new difluorinated quinolone

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175881

High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175881

The first case of Legionnaires' disease in Japan (author's transl)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175881

Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175881

Antimicrobial resistance of Neisseria gonorrhoea in Bangkok: is single-drug treatment passé.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175881

Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175881

Studies on ciprofloxacin therapy of experimental Legionnaires' disease

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3196003

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3196003

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.32.9.1427

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

3196003

1 reference